PrEP – Prä-Expo­si­ti­ons-Pro­phy­laxe

PrEP is a medi­cal pro­tec­tion against HIV. Reli­ably taken, the drug teno­fo­vir / emtri­ci­ta­bine effec­tively pro­tects from HIV, com­pa­ra­ble to the pro­tec­tive effect of con­doms. The PrEP can be taken regu­larly or tem­pora­rily. It is important that you keep to the pat­tern of intake and also have the regu­lar accom­pany­ing exami­na­ti­ons done.

PrEP will now be paid by Ger­man health insuran­ces for people with an increa­sed risk of HIV infec­tion, too!

The accord­ing law came into force on 11 May 2019. Accord­in­gly, the drug and the necessary accom­pany­ing medi­cal exami­na­ti­ons are paid by the health insurance com­pa­nies.Since Sep­tem­ber 1st.2019 the public health ser­vice has an imple­men­ta­tion agree­ment, which regu­la­tes the pre­scrip­tion and bil­ling moda­li­ties for phy­si­ci­ans and pati­ents.

Accord­in­gly, the PrEP can be pre­scri­bed for:

  • men who have inter­course with men (MSM) or trans­gen­der per­sons who report having had anal sex wit­hout a con­dom wit­hin the past 3 to 6 mon­ths and / or pro­bably in the next few mon­ths or a recent STI (Sexual Infec­tious Infec­tious Disease) 12 mon­ths
  • sero­dis­cordant con­stel­la­ti­ons with a vire­mic HIV-posi­tive part­ner wit­hout anti­re­tro­vi­ral the­rapy (ART), a non-sup­pres­sive ART, or in the initial phase of ART (HIV RNA not less than 200 RNA copies / ml for 6 mon­ths)
  • after indi­vi­dual and situa­tio­nal risk assess­ment, drug-injec­ting indi­vi­du­als wit­hout the use of ste­rile injec­tion mate­ri­als
  • after indi­vi­dual and situa­tio­nal risk assess­ment, per­sons with inter­course wit­hout a con­dom with a part­ner who is likely to have undia­gno­sed HIV infec­tion (eg one part­ner from high-pre­va­lence coun­tries or with high-risk sexual prac­tices).

(Source: Agree­ment on the Pre­ven­tion of HIV Pre-Expo­sure for the Pre­ven­tion of HIV Infec­tion in accordance with § 20j SGB V, as amen­ded on 24.07.2019, effec­tive from 01.09.2019 (PDF, 2.0 MB)

Unfor­tu­n­a­tely, the law does not apply to pri­vate health insuran­ces. For the time being, people with  pri­vate health insurance should ask their health insurance com­pany whe­ther they will reim­burs­e­the costs of the medi­ca­tion and the accom­pany­ing exami­na­ti­ons.

If you are con­si­de­ring PreP or just want to inform yours­elf, feel free to con­tact us! We will give you the necessary infor­ma­tion to help you to sup­port your decision. Inci­dent­ally, the con­ver­sa­tion with us is accep­ted from the pre­scrib­ing Hano­ve­r­ian doc­tors as a con­sul­ta­tion accord­ing to the pre­scrip­tion policy.
Cur­rent infor­ma­ti­ons on PrEP you‘ll find on these pages:

The fol­lo­wing doc­tors in Hannover are cur­r­ently pre­scrib­ing PrEP:

Since 01.12.2017 teno­fo­vir / emtri­ci­ta­bine is avail­able in every Ger­man phar­macy with a pre­scrip­tion fron a doc­tor. You can get the pre­pa­ra­tion of the Ger­man Blis­ter AG in Hannover here:

 

Coun­sel­ling on PrEP

Jür­gen Maaß
Phone: 0511 / 360 696 16
j.​maass@​hannover.​aidshilfe.​de